Ask a Question
Coherent

Search Results

37 - 48 of 167 Products for 'ela' Page 4 of 14 |

ela

FCO Decision

FCO Decision

…lower accounts receivable DSO and higher cash. Quarterly Results Second quarter bookings of $220.6 million increased 35.7% sequentially and declined 15.8% compared to the prior year period, which included a $100 million order for ELA equipment. The book-to-bill for the second quarter was 1.08.

Coherent%2C Inc. Prepared Remarks 1Q17 FINAL.pdf

Coherent%2C Inc. Prepared Remarks 1Q17 FINAL.pdf

…bookings granularity, which gives competitors insight into our business. Our bookings volatility has and will continue to be high by virtue of the ELA business where high ASPs can induce large swings in bookings. These swings are not indicative of the long-term potential of the business. Finally,…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

FCO Decision

FCO Decision

…with revenues of $188.5 million and pro forma earnings of $0.82 per diluted share. The third quarter revenue does not include the third LB 1500 ELA system that we had previously indicated may ship in the third quarter. The customer requested that we deliver this unit in the fourth quarter, as…

FCO Decision

FCO Decision

…exchange rate fluctuations. Compared to the previous quarter, net sales decreased $15.2 million or 7.5% which is partially due to the Linebeam 1500 ELA system shift to the fourth quarter and a slowdown in semiconductor investments. In addition, our medical ophthalmic revenues declined following a…

Powered by Site Search powered by SLI Systems

Please Read Before Continuing

Risk factors: Except for the historical information contained here, many of the matters discussed in this Web site are forward-looking statements, based on expectations at the time they were made, that involve risks and uncertainties that could cause our results to differ materially from those expressed or implied by such statements. These risks are detailed in the “Factors That May Affect Future Results” section of our latest 10-K or 10-Q filing. Coherent assumes no obligation to update these forward-looking statements.


I have read the terms and conditions